The proportion of studies that use one-tailed statistical significance tests (IT) in a population of studies targeted by a meta-analysis can affecl the bias of the sample effect sizes (sample ESs, or ds) that arc accessible to the meta-analyst. H. C.
significant results to journals in anticipation of the publication bias (see Begg, 1994; Greenhouse & lyengar, 1994; Hedges, 1984) . Therefore, concern has been expressed (Begg, 1994; Hedges, 1984; Kraemer et al., 1998 ) that this accessibility bias could result in biased estimates of the population ESs (Ss) targeted by meta-analyses. Kraemer et al.'s (1998) new model for the estimation of this bias and by demonstrating important implications of this model (see Begg, 1994; Greenhouse & lyengar, 1994; and Hedges, 1984 , for other models; and Lane & Dunlap, 1978 , for Monte Carlo studies of this bias). However, the implications discussed by Kraemer et al. were based on the assumption that tests of significance used in studies targeted by the meta-analyses were onetailed tests; but accessibility of ESs from studies yielding statistically significant two-tailed tests can lead to biased estimates of 8s that are quite different from those of one-tailed tests.
The present article is concerned with the effect that the directionality of these significance tests (that is, whether these tests are one-or two-tailed) has on the bias of accessible ESs, when sample sizes and 8s arc of realistic magnitudes. These directionality effects (i.e., differences in ES biases associated with onetailed vs. two-tailed tests) are considered to be noteworthy because they tend to be large under conditions 
Comparison of ES Biases of Studies Using One-Tailed Tests With ES Biases of Studies
Using Two-Tailed Tests
Kraemer et al. 's (1998) Model
The model proposed by Kraemer et al. (1998) f'^} = standard score separating significant from nonsignificant ds!8; Z u = the 11 -a] 100th percentile of the standard normal distribution; $(Z) = density of the normal curve at Z; <t(Z) = value of the standard normal cumulative function for Z; N = total sample size of the study; P = proportion of the total sample assigned to the treatment group; P' = proportion of the total sample assigned to the control group. Kraemer et al. 's (1998) Model When the studies in the targeted population use symmetric two-tailed tests (with right-tail p values of [p < a/2], and of \p > (1 -a/2)]) and when results of significance tests determine inclusion (and exclusion) of studies from meta-analyses, the bias of the accessible ESs can be determined from the expected value for two parts of a doubly truncated normal distribution whose mean and standard deviation (prior to truncation) are [VAW (8)] and 1, respectively. This distribution will be called the ^-normal distribution. These two parts correspond to studies whose absolute </s are sufficiently large to yield statistically significant results. The expected value of d for the combined parts Similarly, Hedges (1984) pointed out that "a survey of three psychology journals by Sterling (1959) and Bozarth and Roberts (1972) showed that 97% and 94%, respectively, of the articles examined that used statistics rejected the statistical null hypothesis at the a = .05 level" (p. 63). He noted that these percentages exceeded by far the percentages (between 25% and 85%) that would be expected from results of surveys of statistical power in psychological research.
Modification of
Hedges also drew attention to evidence of the intent of editorial policy of some journals to discourage publication of research that does not yield significant results. Greenwald (1975) also found that 60% of researchers who obtained significant results intended to submit their results for publication, but that only 6% of researchers who obtained nonsignificant results intended to do so (see Cooper, 1984) . Figure 1 ) using SYSTAT Version 7.0.1 (Wilkinson, 1996a (Wilkinson, , 1996b for two-sample studies of size N = 20.
Equation 1 was used to obtain these expected rfs given Kraemer et al.'s (1998) model and given that studies targeted by the meta-analysis used one-tailed tests. As noted by an anonymous reviewer, most metaanalyses include both studies that used one-tailed tests and studies that used two-tailed tests. Therefore, the curves in Figure 2 (and in Figure 1 ), which reflect expected bias with either 100% one-tailed tests or 0%
one-tailed tests, provide only boundary information about bias in these meta-analyses. were calculated by linear interpolation between coordinates of points plotted in Figure 2 . As in the case of Figure 2 , extreme accessibility bias was assumed in generating Figure 5 : The meta-analyses were assumed to include only studies that yielded statistically significant results (a = .05; see Footnote 1).
Implications for the Interpretation of Meta-Analyses of Therapy Outcome Studies
In this article a therapy efficacy study or therapy effectiveness study refers to a sludy that contrasts a treatment group with a control group. Consistent with the contemporary distinction, therapy efficacy studies refers to controlled studies conducted under laboratory or quasilaboratory conditions, whereas therapy effectiveness studies refers to studies conducted in clinical settings in which usual control procedures are not implemented (see Kazdin, 1998) . Therapy efficacy and therapy effectiveness studies will collectively be called therapy efficacy/effectiveness studies below. The expression comparative outcome study will refer to a study that contrasts alternative treatments for a disorder. This breakdown of studies included in meta-analyses of therapy outcome studies is consistent with the categorization that is often used in these meta-analyses (see, e.g., Kazdin & Bass, 1989; Shapiro & Shapiro, 1983) . When u is kept constant, the principal factors affecting the bias of ESs of studies typically included in meta-analyses are (a) the sample size N; (b) the true ES, 8; and (c) as demonstrated in Figures 1, 2 , and 5, the directionality of significance tests used in the targeted studies. Because the last two of these factors are believed to differ between therapy efficacy/effectiveness studies and comparative outcome studies, the implications of the results described in the previous section are first discussed in relation to each of these two categories of studies. (Hedges, 1984) and estimated biases (using Kraemer et al.'s, 1998 , method) of accessible effect sizes (two-tailed tests, a -.05).
Implications for the Interpretation of Meta-Analyses of Comparative Outcome Studies
The typical sample size used in comparative outcome studies is only slightly larger than 10 per group (see Kazdin & Bass, 1989; Shapiro & Shapiro, 1983 
Implications for the Interpretation of Meta-Analyses of Therapy Efficacy Studies: Treatment Versus Control Conditions
The assumption of unidirectionality of significance tests made in Kraemer et al.'s (1998) derivations is undoubtedly more realistic in the case of therapy efficacy/effectiveness studies (contrasting treatment vs.
control groups) than in the case of comparative outcome studies (contrasting treatment vs. treatment groups) because of differences in real-world actions that these studies are designed to support (see Kazdin, 1998 In therapy efficacy/effectiveness studies, however, the actions to be taken are either to administer the treatment or not to administer the treatment. With respect to these actions, the investigator simply wants to know whether the treatment is significantly better than the control (see Jones, 1954; Kimmel, 1957) .
There is no interest in distinguishing between "significantly worse results" and "not significantly different results" because the real-world action associated with both of these results is precisely the same-that is, not to administer the treatment. As noted by Kimmel (1957) , one-tailed tests should be used when "results in the unpredicted direction will under no conditions be used to determine a course of behavior different in any way from that determined by no difference at all" (p. 353). Therefore, it seems reasonable to assume that one-tailed tests are much more likely to be used, as well as much more likely to be accepted by reviewers and editors, in therapy efficacy/ effectiveness studies than in comparative outcome studies. If it could be assumed that the majority of therapy efficacy/effectiveness studies used one-tailed tests, then the curves for unidirectional tests (in Figures 1 and 2 ), based on Kraemer et al.'s (1998) assumption, would more accurately reflect the ES bias 2 As S increases, the proportion of significant negative ds (which lower the bias) decreases, and therefore the weight of the expected value of these rfs (Equation 2) also decreases. It is the nonnegligible proportion of significant negative ds of two-tailed tests that causes the bias to be smaller for two-tailed tests than for one-tailed tests. Beyond 8 -2.5, this proportion becomes negligible, so that the expected value of d is determined by significant positive rfs.
The larger bias for two-tailed tests beyond S == 2.5 reflects the fact that the expected value of the positive </s, in the case of two-tailed tests, is determined by a truncation (corresponding to a < .025) of the 5-normal distribution more extreme than the truncation for one-tailed tests (corresponding to QL < .05).
of accessible therapy efficacy/effectiveness studies than would the curves for nondirectional tests. classes of comparative outcome studies in which directional tests could be preferred for theoretical and/or practical reasons, for example, studies that compare the efficacy of systematic desensitization to thai of systematic desensitization with medication. 4 However, according to Strube, Gardner, and Hartman (1985) , studies yielding results in one direction are easier to retrieve than studies yielding results in the opposite direction, despite their nearly equal magnitude.... Such biases probably reflect the fact that some findings better "fit'" the prevailing scientific atmosphere (Zeitgeist) and are scrutinized less closely than are novel or counterintuitive results. This differential evaluation is likely to uncover "flaws" that preclude the latter studies from being published, (p. 67)
These findings may in fact be viewed as "Type III errors" (see Leventhal & Huynh, 1996) by reviewers and editors. As noted by Cooper (1984) , "journal reviewers appear to look less favorably on studies that conflict with conventional wisdom than studies that support it" (p. 42). Thus, to the extent that there exists a bias against publishing statistically significant results that are in the "wrong" direction, accessibility bias would be present with studies that used two-tailed tests when 8 = 0. ies (which support the first component of the Dodo bird verdict) and ESs reported in meta-analyses of comparative outcome studies (which support the second component) may reflect the more extensive use of one-tailed tests in the therapy efficacy studies than in the comparative outcome studies.
As noted above, there is usually little or no justification for one-tailed tests in comparative outcome studies, but there are defensible a priori reasons for one-tailed tests in therapy efficacy/effectiveness studies. The fact that one-tailed tests may be justified in psychotherapy efficacy/effectiveness studies, however, in no way attenuates the problem of large overestimation biases that are associated with significant tests in these studies.
Figures 1, 2, and 5 also suggest that factors that influence the extent of use of one-versus two-tailed tests should be considered in the interpretation of results of both types of meta-analyses. In addition to the factor noted above (viz., type of actions that results of studies are meant to support), it is suggested that the size of the study may also affect the extent of use of one-tailed tests. Researchers may use these tests more frequently with small studies, to increase the notoriously low statistical power of small sample studies.
Use of one-tailed tests instead of two-tailed tests as a means of increasing statistical power has in fact been recommended (when justified) by several authors (e.g., Jones, 1954; Lipsey, 1990; Schuerman, 1977) .
Once more, it must be noted that justifiability of onetailed tests does not eliminate or reduce the problems of large biases of estimates of ESs.
5
Small But Important True ESs and the Directionality of Significance Tests of Hypotheses About These Effects A recent trend in discussions of ESs in the clinical psychology literature has been an emphasis on the potential importance of small or very small true ESs (see, e.g., Kraemer & Rosenthal, 1999; Prentice & Miller, 1992; Rosenthal, 1995 : Rosnow & Rosenthal, 1996 Tolan, 1998) . Rosenthal (1995) , for example, drew attention to the fact that in a large, randomized, double-blind study of the effect of aspirin on heart attack, a very important ES (measured on the r scale) was found to be .034. This effect was judged to be of sufficient importance for early termination of the study on the grounds that continued assignment of participants to the control condition would have been unethical. Converted to the Cohen d scale, this effect is 0.07, which is about one third the size of Cohen's "Small ES" (d = 0.2). Rosenthal (1995) Figures 1 and 2 show that the largest differences in biases of accessible ESs of one-tailed and two-tailed tests occur for small and very small true ESs. Thus, it is clear that the interpretations of meta-analyses of studies that focus on true ESs that are likely to he small can be very different depending on whether one-or two-tailed tests were used in the relevant studies, and that therefore the proportion of these studies that use one-tailed tests should be considered relevant to these interpretations. Figure 5 provides estimates of how this proportion affects the bias.
Conclusions
It is well-known that results of significance tests affect the accessibility of ES. The problems of estimating biases caused by accessibility have received less attention (for notable exceptions, see Begg, 1994; Greenhouse & lyengar, 1994; Hedges, 1984; Kraemer et al., 1998; Lane & Dunlap, 1978) . The effect of directionality of significance tests (whether tests are one-or two-tailed) of targeted studies on the bias of ESs of accessible studies has received the least attention. The present article shows that the directionality of significance tests used in targeted studies is a very important determiner of the size of this bias whenever sample sizes and true ESs are small. Given a true ES of zero, the accessibility of ESs associated with significant one-tailed tests can lead to an estimated ES that actually exceeds the average ES reported in metaanalyses of psychotherapy efficacy/effectiveness studies. Fn contrast, accessibility of significant twotailed tests does not lead to any overestimation of a true ES of zero (if it can be assumed that the publication bias against statistically significant results that are in the "wrong" direction is negligible; see An anonymous reviewer suggested that these biases might in fact be grounds for recommending against the use of directional significance tests. note 4). Because sample sizes of studies included in meta-analyses are typically small, and because true ESs are often expected to be small, the combined effects of accessibility and directionality of significance tests used in the targeted studies should be considered in the interpretation of these meta-analyses. In particular, accurate assessment of (a) the extent to which statistical significance determines accessibility and (b) the proportion of targeted studies that use one-tailed tests may allow more realistic estimation of biases of ESs in existing as well as in future metaanalyses.
